Publication:
89 Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging

No Thumbnail Available

Date

2011

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

American Chemical Society
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Keliher, Edmund J., Jeongsoo Yoo, Matthias Nahrendorf, Jason S. Lewis, Brett Marinelli, Andita Newton, Mikael J. Pittet, and Ralph Weissleder. 2011. “89Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging.” Bioconjugate Chemistry 22 (12): 2383–89. https://doi.org/10.1021/bc200405d.

Research Data

Abstract

Tissue macrophages play a critical role both in normal physiology and in disease states. However, because of a lack of specific imaging agents, we continue to have a poor understanding of their absolute numbers, flux rates, and functional states in different tissues. Here, we describe a new macrophage specific positron emission tomography imaging agent, labeled with zirconium-89 (Zr-89), that was based on a cross-linked, short chain dextran nanoparticle (13 nm). Following systemic administration, the particle demonstrated a vascular half-life of 3.9 h and was found to be located primarily in tissue resident macrophages rather than other white blood cells. Subsequent imaging of the probe using a xenograft mouse model of cancer allowed for quantitation of tumor-associated macrophage numbers, which are of major interest in emerging molecular targeting strategies. It is likely that the material described, which allows the visualization of macrophage biology in vivo, will likewise be useful for a multitude of human applications.

Description

Other Available Sources

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories